
The tumor microenvironment is an ecological system made by malignant tumor cells. Important processes related to tumor development and survival are regulated by the tumor microenvironment. Lymphoma, especially the Hodgkin subtype, is one of many malignant tumors in which, many studies focused on the pathological role of tumor microenvironment components because Classic Hodgkin Lymphoma is characterized by a large number of reactive, non-neoplastic cells with few (<1%) malignant Reed-Sternberg cells in the tumor microenvironment. This narrative review will focus on the cellular composition of the Hodgkin lymphoma tumor microenvironment and their pathological interaction, which contributes to the pathogenesis of Hodgkin lymphoma, as well as various cytokines and chemokines secreted with characteristic immunohistochemistry. Lastly, this review will discuss the clinical relevance of the tumor microenvironment by illustrating drugs targeting the tumor microenvironment and their mechanism of action. Keywords Hodgkin lymphoma, immunohistochemistry, Reed-Sternberg cells, tumor microenvironment
Background Retrograde intrarenal surgery (RIRS) has been expanded and now it is a common endourologic procedure used for treating renal stones with high success rates and is considered a safe and optimal treatment modality for renal stones of different sizes. Objective To evaluate the safety and efficiency of RIRS technique without using ureteric access sheath in treating 1-2 cm renal stones. Methods An observational study conducted at Al-Imamein Al-Kadhimein Medical City and Al-Salama Private Hospital for 21 patients (17 males and 4 female) who had 1-2 cm renal stones burden. All patients were presented 2 weeks prior to RIRS operation. Flexible ureterorenoscopy (f-URS) was performed under general or spinal anesthesia using laser lithotripsy. The patients were followed by ultrasound 1 month post-operatively to assess stone free rate. Results The mean age of patients was 42.1±17.2 years (range 19-71 years). Males comprised the majority of cases (80.9%). The mean stone size was 1.5±0.35 cm with mean density of 854.7±232.3 Hounsfield units. The mean preoperative stent duration and operative time was 3.1±2.1 weeks and 54.1±14.6 minutes, respectively. The vast majority of patients (95.2%) were discharged from hospital within 24 hours after the procedure. After 1 month of follow up, success, as defined by no stone or clinically-insignificant stone fragment ≤4 mm, was achieved in 19 patients (90.5%), while residual stone fragment >4 mm was observed in two patients (9.5%). As high as 95.2% had only minor complications (grade I & II) in the form of transient hematuria (85.7%), transient fever relieved by antipyretics (19%). Two patients (9.5%) had urinary tract infection and 1 patient needed intervention under general anesthesia for ureteric stent replacement. Conclusion The sheathless RIRS is an effective and safe procedure for management of 1-2 cm renal stones. Keywords Sheathless retrograde intrarenal surgery, renal stone.
Background Early detection of renal stress in patients with inflammatory bowel disease (IBD) is crucial to prevent progression to overt kidney injury. The tissue inhibitor of metalloproteinases-2 (TIMP-2) * insulin-like growth factor binding protein 7 (IGFBP7) index has been proposed as a sensitive, non-invasive biomarker for subclinical renal involvement. Objective To assess the utility of the TIMP-2 * IGFBP7 index as a marker of renal stress by comparing its levels between patients with IBD and healthy controls. Methods A case-control study was conducted at the Department of Chemistry and Biochemistry, College of Medicine, Al-Nahrain University from December 2024 to March 2025, including 60 patients with IBD and 60 age- and sex-matched healthy individuals. Disease activity was assessed using the Mayo Score for ulcerative colitis and the Crohn’s disease activity index for Crohn’s disease. Serum levels of TIMP-2 and IGFBP7 were measured and compared between groups. Receiver operating characteristic analysis was performed to evaluate discriminative power. Results TIMP-2 * IGFBP7 index was significantly higher in patients (0.207 ± 0.1166) compared to controls (0.16 ± 0.11, p = 0.0185). TIMP-2 alone showed a significant elevation, while IGFBP7 index did not differ between groups. Receiver operating characteristic analysis indicated moderate discriminative ability (area under curve = 0. 0.59). Patients with active disease demonstrated higher index levels than those in remission, suggesting a potential association with ongoing intestinal inflammation. Conclusion The TIMP-2 * IGFBP7 index is non-invasive marker of early renal stress in patients with IBD. However, its moderate discriminative performance suggests that it should be interpreted in conjunction with other clinical and laboratory parameters. Keywords Inflammatory bowel disease, subclinical kidney injury, tissue inhibitor of metalloproteinases-2, insulin-like growth factor binding protein 7, index
Background Pleural effusion (PE) is an abnormal buildup of fluid in the pleural space that typically results from excessive fluid production and/or reduced lymphatic absorption. It is still difficult to distinguish between benign and malignant exudative PE in clinical settings. Matrix metalloproteinase-9 (MMP-9) is linked to tumor aggressiveness and the potential for metastasis. It also plays a part in chronic inflammation. Numerous studies have shown that MMP-9 may be a useful marker to distinguish between benign and malignant exudative PE. Objective To assess the diagnostic utility of tissue inhibitor of metalloproteinase-1 (TIMP-1) and MMP-9 in separating benign from malignant exudative PEs. Methods A case-control study comprised 60 patients with malignant PEs and 60 patients with benign PEs who visited Al-Imamein Al-Kadhimein Medical City. All patients were examined and asked about their medical history, and they had measured the serum level of MMP-9 and TIMP-1 as markers for differentiation between benign and malignant exudative pleural effusion. It was determined by using quantitative sandwich (ELISA) technique. Results The levels of MMP-9 and TIMP-1 in the serum of patients with malignant PE are higher than in benign PE, with a sensitivity of MMP-9 and TIMP-1 (60% and 56.67%), specificity (93.33% and 95%), AUC (0.774 and 0.782) and the optimal cutoff value was >11.784 ng/ml and 1089.19 pg/ml) respectively with p-value ˂0.001. Conclusion MMP-9 and TIMP-1 might be valuable markers in differentiating benign from malignant PEs. Keywords Exudative pleural effusion, lactate dehydrogenase, matrix metalloproteinase-9, tissue inhibitor metalloproteinase-1.
Background Bladder cancer (BC) is the tenth most prevalent cancer worldwide. The fibroblast growth factor receptor 3 (FGFR3) controls essential signaling pathways that govern several cellular processes, including proliferation and migration. Cytokeratin-19 (CYFRA21-1) is a protein belonging to the intermediate filament family that serves as an essential component of the cellular cytoskeleton. Although FGFR3 and CYFRA21-1 have been reported as prognostic factor in several malignancies, their association with muscle-invasive bladder cancers (MIBC) and non-muscle-invasive bladder cancers (NMIBC) has not yet been well-studied.Objective To determine the association of FGFR3 and CYFRA21-1 levels with MIBC and NMIBC in a sample of the Iraqi population.Methods This case-control study involved 40 NMIBC and 40 MIBC participants. The serum levels of FGFR3 and CYFRA21-1 were determined using the enzyme-linked immunosorbent assay (ELISA) technique.Results In the MIBC patients\' group, smoking was significantly more prevalent than in the NMIBC group. FGFR3 levels were significantly higher in NMIBC groups. While CYFRA21-1 significantly increased in MIBC groups. According to the logistic regression model, CYFRA21-1 levels are associated with an increased risk of developing MIBC disease by nearly 2-fold (odd ratio: 1.44, 95% confidence interval: 1.31-1.57, p value <0.001).Conclusion CYFRA21-1 levels were associated with the development of MIBC and could be used as a predictive marker for the development of the disease in a sample of the Iraqi population.Keywords Muscle invasive bladder cancer; non-muscle invasive bladder cancer; fibroblast growth factor 3 receptor; CYFRA21-1.